PHE_COVID-19 Emergency Purchases ECM8106
Details
- Value
- GBP 20,744
- Topic
- Clinical products
- Published
- 1 April 2021
- Submission
- 1 December 2019
- Source
- uk:contracts_finder
Tender description
Emergency purchase of laboratory products, consumables, reagents etc to assist Public Health England support the Government in its response to the Covid-19 pandemic. The purchase covered by this notice are Antibody Rabbit PAb, Antigen Affinity Purified - 10ml. Due to the emergency nature of these purchases, no formal contract was awarded but PHE's Purchase Order formed the contract. An example Purchase Order is attached.
Timeline
- Completed: Submission date1 December 2019
- Completed: Tender published1 April 2021Current notice
About the buyer
Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33698000 · Clinical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@public-health-england.gov |
1 similar open tenders
See more open tenders related to PHE_COVID-19 Emergency Purchases ECM8106.
- Open tender
MEDICAL TECHNOLOLGY (MEDTECH) INNOVATION DPS
Related buyers
Buyers similar to Public Health England.
- 2,588£1.6bn
- 1,675£204.4bn
- 874£19.4bn
- 670£8.7bn
- 454£15.4bn
- 423£3.8bn
- 335£20.0m
- 284£365.8m
- 256£233.2m
- 252£892.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
